Factory Mutual Insurance Co. lifted its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 2.6% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 98,935 shares of the medical research company's stock after acquiring an additional 2,500 shares during the quarter. Factory

Fiera Capital Corp lowered its position in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 3.1% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 151,374 shares of the medical research company's stock after selling 4,798 shares during the quarter. Fiera Capital

Insights into Glenview Capital Management's Fourth Quarter 2025 Moves Larry Robbins (Trades, Portfolio) recently submitted the 13F filing for the fourth quarte

Crestwood Advisors Group LLC raised its stake in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 4.7% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 99,793 shares of the medical research company's stock after purchasing an additional 4,484

Fifth Third Bancorp increased its position in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 2.0% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 327,665 shares of the medical research company's stock after buying an additional 6,440 shares during the

Assetmark Inc. increased its position in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 31.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 30,631 shares of the medical research company's stock after acquiring an additional 7,400 shares during

Cornerstone Investment Partners LLC purchased a new stake in Thermo Fisher Scientific Inc. (NYSE: TMO) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 85,342 shares of the medical research company's stock, valued at approximately $41,393,000. A number of other institutional

Caprock Group LLC acquired a new stake in Thermo Fisher Scientific Inc. (NYSE: TMO) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 8,500 shares of the medical research company's stock, valued at approximately $4,188,000. Other hedge funds and other institutional investors have

Atria Investments Inc trimmed its stake in Thermo Fisher Scientific Inc. (NYSE: TMO) by 31.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 33,246 shares of the medical research company's stock after selling 15,333 shares during the

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with Datavant, the data collaboration platform trusted for healthcare, to make it easier for pharmaceutical and biotech companies to connect real-world data with clinical research—helping them generate stronger evidence, faster. Thermo Fisher's PPD™ clinical research business and Datavant will enable secure connection and analysis of real-world data (RWD.